Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

PBYI - Puma Biotechnology, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Rock Sexton, Aug 22, 2016.

  1. Rock Sexton

    Rock Sexton Meat Popsicle

    Joined:
    Apr 6, 2016
    Messages:
    582
    Likes Received:
    617
    Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) and PB272 (neratinib (intravenous) that are in Phase-III and Phase-II clinical trials for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, and HER2 mutation-positive solid tumors. The company is also developing PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.

    [​IMG]
     
  2. Rock Sexton

    Rock Sexton Meat Popsicle

    Joined:
    Apr 6, 2016
    Messages:
    582
    Likes Received:
    617
    A jump back inside the low of 2015 should ideally complete the reversion back to the point of control for 2015 (approx 78.40)

    • The minor pullback 4 weeks ago was on very light supply - signalling strength to longs.
    • There was also an absorption candle back in December 2015, signalling attractiveness of prices around the 60 level. I haven't gone to look back (honestly don't really care), but I imagine there was a fundamental event that shook the tree in the short term.

    PBYI.JPG
     
    #2 Rock Sexton, Aug 22, 2016
    Last edited: Aug 22, 2016
  3. Rock Sexton

    Rock Sexton Meat Popsicle

    Joined:
    Apr 6, 2016
    Messages:
    582
    Likes Received:
    617
    Booooooom. Cracked the 62 level today.

    PBYIupdate.JPG
     
  4. Danny T

    Danny T Member

    Joined:
    Nov 9, 2016
    Messages:
    39
    Likes Received:
    7
    Missed the bounce on this one.... What a nice recovery from the drop this morning.
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    6,805
    Likes Received:
    1,878
    Down over 27% pre-market on missed earnings and a downgrade

    upload_2017-3-2_6-38-20.png
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,771
    Likes Received:
    1,839
    Nice +8% mover this morning

    Puma jumps after FDA approval of breast-cancer treatment

    Puma Biotechnology Inc. PBYI, +6.66% jumped as much as 11.5% in late trading Monday after the company announced that the Food and Drug Administration had approved a breast-cancer treatment for medical use. The medicine, which will be marketed as Nerlynx and is expected to hit the market in September, is used after traditional treatment to avoid recurrence of HER2 breast cancer.
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,771
    Likes Received:
    1,839
    PBYI Stock Plunges After Goldman Screams "Sell"
    Skepticism has been ramping up on PBYI
     

Share This Page